McAndrews McAndrews

  • Professionals
  • Practices & Industries
  • About
  • News & Insights
  • Working Here
  • Contact
  • EN

500 West Madison Street, 34th Floor, Chicago, IL 60661 – T 312.775.8000 – www.mcandrews-ip.com

Troy A. Groetken

tgroetken@mcandrews-ip.com
312.775.8259

Troy A. Groetken Shareholder

312.775.8259

  • Overview
  • Practices & Industries
  • Related Experience
  • Honors & Awards
  • Representative Matters
  • Publications
  • Presentations
  • Professional & Community Involvement

Troy Groetken is a Shareholder, Board Member, and Executive Committee member with McAndrews. He has approximately 25 years of legal experience in the intellectual property field and more than 25 years of technical experience in the pharmaceutical, biotechnological, and chemical fields. He is recognized in the IAM Patent 1000: The World’s Leading Patent Professionals, and has been listed as one of the Best Lawyers in America since 2012.

As a registered U.S. patent practitioner, Troy regularly counsels and is known globally as the “go-to” intellectual property attorney for Fortune 100 and 500 clients regarding complex intellectual property matters involving strategic global patent portfolio development, implementation and enforcement. This is especially the case for matters impacted (e.g., IPR, PGR, advanced patent litigation, including FTC matters) by recent changes caused by the AIA and ANDA/ABLA regulatory schemas. Troy also advises upon and institutes multi-level front-end and back-end licensing programs coordinated with a client-focused business modeling approach including acquisition, divestiture, platform positioning and the like. He strategically addresses multi-jurisdictional intellectual property integration issues, ranging from core and non-core patent portfolio due diligence analysis to global portfolio coordination matters (e.g., coordination of complex U.S. reexamination or reissue proceedings with European, Asian and Australian appeals and opposition), among other services.

Troy regularly assists clients with respect to a broad range of technical disciplines involving the chemical, pharmaceutical and biotechnological arts encompassing new drug (small-molecule, protein, recombinant, combinatorial technologies, assay, etc.) entities, assays, immunoassays, biological molecular technologies, API development and positioning, generic pharmaceuticals, biosimilars, pharmaceutical conjugates, surfactant technologies, agricultural compositions, food-based technologies, animal compositions, gellants, polyols, lubricants, coatings, elastomers, sealants, adhesives, biocides, medical devices, drug delivery formulations, laundry and cleaning products, inorganic and organic synthesis products, pharmaceutical supplements, personal care and cosmetic formulations, oil and gas technologies, alternative fuels, fuel cells, renewable energies, among others.

He also regularly counsels Fortune 100 mechanical and electrical companies with respect to intellectual property matters ranging from heavy-duty industrial products (e.g., diesel engines and aircraft technologies) to small appliances.

Prior to practicing patent law, Troy worked as a clinical consultant pharmacist, supervised drug research programs in coordination with the FDA, evaluated drug management protocols, and performed drug treatment trials on behalf of various hospitals and research institutions.

EDUCATION

  • John Marshall Law School, LL.M., Intellectual Property Law, Honors
  • Drake University Law School, J.D., cum laude
  • Drake University, College of Pharmacy, B.S., Pharmacy, cum laude, Rho Chi

BAR ADMISSIONS/REGISTRATIONS

  • Illinois
  • Iowa
  • United States Supreme Court
  • Federal Circuit Court of Appeals
  • District Courts for the Northern District of Illinois and the Southern District of Iowa
  • U.S. Patent and Trademark Office
  • Registration Certificate (Roll of Patent Agents)
  • Canadian Patent Office

Education

  • John Marshall Law School, LL.M., Intellectual Property Law, Honors
  • Drake University Law School, J.D., cum laude
  • Drake University, College of Pharmacy, B.S., Pharmacy, cum laude, Rho Chi

Practices

  • Design Rights
  • IP Transactions
  • IP Litigation
  • Patent Prosecution
  • Post-Grant Practice
  • Trademarks & Copyrights

Bar Admissions/Registrations

  • Illinois
  • Iowa
  • United States Supreme Court
  • Federal Circuit Court of Appeals
  • District Courts for the Northern District of Illinois and the Southern District of Iowa
  • U.S. Patent and Trademark Office
  • Registration Certificate (Roll of Patent Agents)
  • Canadian Patent Office

Industries

  • Chemical
  • Life Sciences

Related Experience

  • Licensed pharmacist, Illinois, Iowa and Michigan

Honors & Awards

  • IAM Patent 1000: The World’s Leading Patent Professionals
  • Lawyer of the Year, USA – Patents, Lawyer Monthly, 2016
  • Legal Elite Award Winner, 2016
  • The Best Lawyers in America, selected by peers, 2012 – Present
  • Rising Star, Illinois Super Lawyers independent survey, 2008, 2009
  • 40 Illinois Attorneys Under Forty to Watch, Law Bulletin Publishing Company, selected by peers in 2009

Representative Matters

  • Chiesi Farmaceutici s.p.A. v. Mesoblast International Sárl, Patent No. 2298863 (05/03/2016) Subject: Mesenchymal stem cells
  • Fatigue Fracture Technology, LLC v. Navistar, Inc., Case No. 15-cv-5667, (06/25/2015) Subject:  Fracturing technology
  • Kovin Associates, L.P. v. Duo-Gard Industries, Inc., Case No. 15-cv-2058, (03/09/2015) Subject: Roofing technology
  • Desmond Mark Chapman v. Osiris Therapeutics, Inc., Case No. T 1147/15-3.3.08 (07/09/2015) Subject: Mesenchymal stem cells
  • Polyguard Products, Inc. v. W R. Meadows, Inc. (02/28/11 – 03/2012) Subject:  Sealant based product and process
  • Shire LLC v. Travis C. Mickle, Ph.D. and KemPharm, Inc. (09/29/10 – 05/12/12) Subject:  Pharmaceutical conjugates
  • Strawman Limited v. Osiris Therapeutics, Inc. (European Opposition) (2012) Subject:  Joint Repair Using Mesenchymal Stem Cells
  • Cognate Therapeutics Inc.; Harvey Vaughan John Adams v. Osiris Therapeutics, Inc. (European Opposition) (2008) Subject: Muscle regeneration using stem cells
  • Akzo Nobel v. Stepan Company (European Opposition) (2006) Subject:  Surfactant technology

Publications

  • The Critical Importance of Patent Protection for Diagnostics in the COVID-19 Era,  http://www.mddionline.com/legal/critical-importance-patent-protection-diagnostics-covid-19-era,
  • Patents, www.lawyer-monthly.com, LM77-16, p. 87.
  • Inter Partes Review, Development and Procedures, Today’s General Counsel, Vol. 12, No. 1, Feb/Mar 2015.
  • An alternative litigation strategy: ADR + IPR, Insidecounsel.com, March 26, 2014. View File.
  • Should the Supreme Court address claim construction in patent cases?, Insidecounsel.com, March 12, 2014. View File.
  • Sufficiency of disclosure and the great divide between the U.S. and Europe, Insidecounsel.com, February 26, 2014. View File.
  • The perfect storm that led to the rise of design patents, Insidecounsel.com, February 12, 2014. View File.
  • Can personalized medicine survive Prometheus?, Insidecounsel.com, January 29, 2014. View File.
  • Is Patent Reform, Round II a bad idea?, Insidecounsel.com, January 15, 2014. View File.
  • Using Patents as a Business Asset in Today’s Economy, Life Science Leader, July 2011

Presentations

  • Speaker, Artificial Intelligence and Precision Healthcare, BIO International Convention 2022, San Diego, CA, June 15, 2022
  • Best Practices: PGR Procedures, U.S. and Foreign Venues – 2016
  • Best Practices Regarding Patent Prosecution Under 35 U.S.C. § 101, U.S. and Foreign Venues – 2015
  • Best Practices: IPR Procedures, U.S. and Foreign Venues – 2015
  • Best Practices With Respect to U.S.C. § 112, U.S. and Foreign Venues – 2014
  • Best Practices: Controlling Litigation Costs, U.S. and Foreign Venues – 2013
  • “U.S. Patent Reform:  A Major Update,” Numerous U.S. and European venues – October-November 2011 and May 2012
  • “KSR – Practical Approaches,” American Intellectual Property Law Association (AIPLA) Roadshow – June 23, 2011
  • “Biosimilars Legislation in the U.S.,” U.S. and EPO Patent Law Update Symposium – Chicago, May 19, 2011
  • “Biosimilars Legislation in the U.S.,” U.S. and EPO Patent Law Update Symposium – Munich, May 3, 2011

Professional & Community Involvement

  • American Intellectual Property Law Association (AIPLA)
  • American Pharmacists Association (APhA)
  • American Society of Consultant Pharmacists (ASCP)
  • Association of Patent Law Firms (APLF)
  • Federal Circuit Bar Association
  • PTAB Bar Association
  • Batavia Lions Club
  • Batavia Moose Lodge
  • Millcreek Neighborhood Crime Watch Captain

Practices

  • Design Rights
  • IP Transactions
  • IP Litigation
  • Patent Prosecution
  • Post-Grant Practice
  • Trademarks & Copyrights

Industries

  • Chemical
  • Life Sciences
  • Licensed pharmacist, Illinois, Iowa and Michigan
  • IAM Patent 1000: The World’s Leading Patent Professionals
  • Lawyer of the Year, USA – Patents, Lawyer Monthly, 2016
  • Legal Elite Award Winner, 2016
  • The Best Lawyers in America, selected by peers, 2012 – Present
  • Rising Star, Illinois Super Lawyers independent survey, 2008, 2009
  • 40 Illinois Attorneys Under Forty to Watch, Law Bulletin Publishing Company, selected by peers in 2009
  • Chiesi Farmaceutici s.p.A. v. Mesoblast International Sárl, Patent No. 2298863 (05/03/2016) Subject: Mesenchymal stem cells
  • Fatigue Fracture Technology, LLC v. Navistar, Inc., Case No. 15-cv-5667, (06/25/2015) Subject:  Fracturing technology
  • Kovin Associates, L.P. v. Duo-Gard Industries, Inc., Case No. 15-cv-2058, (03/09/2015) Subject: Roofing technology
  • Desmond Mark Chapman v. Osiris Therapeutics, Inc., Case No. T 1147/15-3.3.08 (07/09/2015) Subject: Mesenchymal stem cells
  • Polyguard Products, Inc. v. W R. Meadows, Inc. (02/28/11 – 03/2012) Subject:  Sealant based product and process
  • Shire LLC v. Travis C. Mickle, Ph.D. and KemPharm, Inc. (09/29/10 – 05/12/12) Subject:  Pharmaceutical conjugates
  • Strawman Limited v. Osiris Therapeutics, Inc. (European Opposition) (2012) Subject:  Joint Repair Using Mesenchymal Stem Cells
  • Cognate Therapeutics Inc.; Harvey Vaughan John Adams v. Osiris Therapeutics, Inc. (European Opposition) (2008) Subject: Muscle regeneration using stem cells
  • Akzo Nobel v. Stepan Company (European Opposition) (2006) Subject:  Surfactant technology
  • The Critical Importance of Patent Protection for Diagnostics in the COVID-19 Era,  http://www.mddionline.com/legal/critical-importance-patent-protection-diagnostics-covid-19-era,
  • Patents, www.lawyer-monthly.com, LM77-16, p. 87.
  • Inter Partes Review, Development and Procedures, Today’s General Counsel, Vol. 12, No. 1, Feb/Mar 2015.
  • An alternative litigation strategy: ADR + IPR, Insidecounsel.com, March 26, 2014. View File.
  • Should the Supreme Court address claim construction in patent cases?, Insidecounsel.com, March 12, 2014. View File.
  • Sufficiency of disclosure and the great divide between the U.S. and Europe, Insidecounsel.com, February 26, 2014. View File.
  • The perfect storm that led to the rise of design patents, Insidecounsel.com, February 12, 2014. View File.
  • Can personalized medicine survive Prometheus?, Insidecounsel.com, January 29, 2014. View File.
  • Is Patent Reform, Round II a bad idea?, Insidecounsel.com, January 15, 2014. View File.
  • Using Patents as a Business Asset in Today’s Economy, Life Science Leader, July 2011
  • Speaker, Artificial Intelligence and Precision Healthcare, BIO International Convention 2022, San Diego, CA, June 15, 2022
  • Best Practices: PGR Procedures, U.S. and Foreign Venues – 2016
  • Best Practices Regarding Patent Prosecution Under 35 U.S.C. § 101, U.S. and Foreign Venues – 2015
  • Best Practices: IPR Procedures, U.S. and Foreign Venues – 2015
  • Best Practices With Respect to U.S.C. § 112, U.S. and Foreign Venues – 2014
  • Best Practices: Controlling Litigation Costs, U.S. and Foreign Venues – 2013
  • “U.S. Patent Reform:  A Major Update,” Numerous U.S. and European venues – October-November 2011 and May 2012
  • “KSR – Practical Approaches,” American Intellectual Property Law Association (AIPLA) Roadshow – June 23, 2011
  • “Biosimilars Legislation in the U.S.,” U.S. and EPO Patent Law Update Symposium – Chicago, May 19, 2011
  • “Biosimilars Legislation in the U.S.,” U.S. and EPO Patent Law Update Symposium – Munich, May 3, 2011
  • American Intellectual Property Law Association (AIPLA)
  • American Pharmacists Association (APhA)
  • American Society of Consultant Pharmacists (ASCP)
  • Association of Patent Law Firms (APLF)
  • Federal Circuit Bar Association
  • PTAB Bar Association
  • Batavia Lions Club
  • Batavia Moose Lodge
  • Millcreek Neighborhood Crime Watch Captain
 

Legal Disclaimer Privacy Policy Site Map

© 2023 McAndrews, Held & Malloy, Ltd. All rights reserved. Attorney Advertising. This website does not establish an attorney-client relationship.

Connect

McAndrews, Held & Malloy, Ltd.
500 West Madison Street, 34th Floor
Chicago, IL 60661
T 312.775.8000 | F 312.775.8100

Back to top
  • Professionals
  • Practices & Industries
  • About
  • News & Insights
  • Working Here
  • Contact
  • EN
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.
Agree
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT